Clinical Trial Update: Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating ruxolitinib, human chorionic gonadotropin, and dose-de-escalated corticosteroids for acute graft-versus-host disease ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Human chorionic gonadotropin (human chorionic gonadotropin)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute-graft-versus-host Disease | Phase 1, Phase 2 | Status: TERMINATED